Highbridge Capital Management LLC Becton Dickinson & CO Transaction History

Highbridge Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $2.22 Million - $11.5 Million	-43,475 Reduced 62.74%	25,815 $5.75 Million
Q1 2022 May 11, 2022	BUY	$243.64 - $270.48 $669,766 - $743,549	2,749 Added 4.13%	69,290 $18.4 Million
Q4 2021 Feb 11, 2022	SELL	$230.08 - $250.94 $9.21 Million - $10 Million	-40,028 Reduced 37.56%	66,541 $16.7 Million
Q2 2021 Aug 12, 2021	BUY	$232.65 - $254.58 $5.23 Million - $5.73 Million	22,500 Added 26.76%	106,569 $25.9 Million
Q1 2021 May 12, 2021	SELL	$232.09 - $256.88 $11.4 Million - $12.6 Million	-49,193 Reduced 36.91%	84,069 $20.4 Million
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $6.72 Million - $7.45 Million	30,272 Added 29.39%	133,262 $33.3 Million
Q3 2020 Nov 12, 2020	BUY	$215.77 - $276.76 $22.2 Million - $28.5 Million	102,990 New	102,990 $23.2 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.